Nifty
Sensex
:
:
24085.70
77155.62
96.55 (0.40%)
347.14 (0.45%)

Pharmaceuticals & Drugs

Rating :
51/99

BSE: 524602 | NSE: Not Listed

28.23
17-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  28.7
  •  29.49
  •  28
  •  28.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1188
  •  33552
  •  29.49
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 50.73
  • 113.25
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 73.96
  • N/A
  • 1.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.66%
  • 0.08%
  • 36.22%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 25.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 19.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 27.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 57.37
  • 57.37
  • 57.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.36
  • 3.36
  • 3.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.60
  • 23.60
  • 23.60

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
26.26
8.49
209.31%
14.83
10.00
48.30%
13.72
7.11
92.97%
8.10
11.37
-28.76%
Expenses
25.44
7.95
220.00%
13.84
9.34
48.18%
13.27
6.02
120.43%
7.47
10.83
-31.02%
EBITDA
0.81
0.54
50.00%
1.00
0.66
51.52%
0.46
1.08
-57.41%
0.63
0.54
16.67%
EBIDTM
3.10%
6.35%
6.73%
6.57%
3.34%
15.26%
7.77%
4.75%
Other Income
0.01
0.09
-88.89%
0.00
0.00
0
0.01
0.00
0
0.00
0.00
0
Interest
0.46
-0.10
-
0.34
0.24
41.67%
0.25
0.26
-3.85%
0.46
0.21
119.05%
Depreciation
0.25
0.53
-52.83%
0.14
0.15
-6.67%
0.14
0.15
-6.67%
0.13
0.15
-13.33%
PBT
0.12
0.20
-40.00%
0.53
0.27
96.30%
0.08
0.67
-88.06%
0.04
0.18
-77.78%
Tax
0.03
0.04
-25.00%
0.18
0.28
-35.71%
0.02
0.00
0
0.01
0.00
0
PAT
0.09
0.16
-43.75%
0.35
-0.01
-
0.06
0.67
-91.04%
0.03
0.18
-83.33%
PATM
0.33%
1.85%
2.35%
-0.13%
0.44%
9.44%
0.31%
1.56%
EPS
0.05
0.13
-61.54%
0.11
-0.01
-
0.03
0.31
-90.32%
0.02
0.15
-86.67%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Net Sales
62.91
36.96
34.08
18.73
Net Sales Growth
70.16%
8.45%
81.95%
 
Cost Of Goods Sold
53.84
29.34
27.30
15.95
Gross Profit
9.07
7.62
6.77
2.78
GP Margin
14.42%
20.62%
19.87%
14.84%
Total Expenditure
60.02
34.14
31.26
17.58
Power & Fuel Cost
-
0.11
0.15
0.04
% Of Sales
-
0.30%
0.44%
0.21%
Employee Cost
-
2.96
2.33
0.64
% Of Sales
-
8.01%
6.84%
3.42%
Manufacturing Exp.
-
0.24
0.09
0.05
% Of Sales
-
0.65%
0.26%
0.27%
General & Admin Exp.
-
1.32
1.28
0.82
% Of Sales
-
3.57%
3.76%
4.38%
Selling & Distn. Exp.
-
0.08
0.06
0.05
% Of Sales
-
0.22%
0.18%
0.27%
Miscellaneous Exp.
-
0.10
0.06
0.02
% Of Sales
-
0.27%
0.18%
0.11%
EBITDA
2.90
2.82
2.82
1.15
EBITDA Margin
4.61%
7.63%
8.27%
6.14%
Other Income
0.02
0.09
0.03
0.19
Interest
1.51
0.99
0.93
0.43
Depreciation
0.66
0.61
0.73
0.59
PBT
0.77
1.32
1.19
0.33
Tax
0.24
0.32
0.24
0.07
Tax Rate
31.17%
24.24%
20.17%
21.21%
PAT
0.53
0.54
0.52
0.26
PAT before Minority Interest
0.34
0.99
0.95
0.26
Minority Interest
-0.19
-0.45
-0.43
0.00
PAT Margin
0.84%
1.46%
1.53%
1.39%
PAT Growth
-47.00%
3.85%
100.00%
 
EPS
0.29
0.30
0.29
0.14

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Shareholder's Funds
12.65
12.28
3.08
Share Capital
12.00
12.00
3.00
Total Reserves
0.65
0.28
0.08
Non-Current Liabilities
9.06
5.26
7.69
Secured Loans
2.36
1.78
1.97
Unsecured Loans
6.63
3.39
5.68
Long Term Provisions
0.00
0.00
0.00
Current Liabilities
14.03
12.24
7.35
Trade Payables
4.36
4.12
0.24
Other Current Liabilities
1.16
0.18
0.37
Short Term Borrowings
8.16
7.53
6.56
Short Term Provisions
0.35
0.41
0.19
Total Liabilities
38.91
32.57
20.17
Net Block
3.95
4.48
5.03
Gross Block
5.99
5.91
5.03
Accumulated Depreciation
2.04
1.43
0.00
Non Current Assets
8.03
5.98
5.10
Capital Work in Progress
0.00
0.00
0.00
Non Current Investment
1.40
1.40
0.00
Long Term Loans & Adv.
0.00
0.10
0.07
Other Non Current Assets
2.68
0.00
0.00
Current Assets
30.88
26.56
15.06
Current Investments
0.00
0.00
0.00
Inventories
8.51
6.47
2.71
Sundry Debtors
18.76
14.52
6.62
Cash & Bank
0.12
0.04
0.16
Other Current Assets
3.50
1.44
1.15
Short Term Loans & Adv.
2.06
4.09
4.42
Net Current Assets
16.85
14.33
7.71
Total Assets
38.92
32.55
20.18

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Cash From Operating Activity
-4.93
-4.13
-1.10
PBT
1.32
1.19
0.33
Adjustment
1.60
1.66
1.01
Changes in Working Capital
-7.52
-6.76
-2.44
Cash after chg. in Working capital
-4.60
-3.91
-1.10
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.33
-0.22
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-0.08
-1.58
-5.30
Net Fixed Assets
0.00
0.00
Net Investments
0.00
-1.40
Others
-0.08
-0.18
Cash from Financing Activity
5.09
5.59
4.47
Net Cash Inflow / Outflow
0.08
-0.11
-1.93
Opening Cash & Equivalents
0.04
0.16
2.09
Closing Cash & Equivalent
0.12
0.04
0.16

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Book Value (Rs.)
10.54
10.22
3.56
ROA
2.78%
3.59%
1.28%
ROE
7.98%
12.36%
8.40%
ROCE
8.41%
10.04%
4.39%
Fixed Asset Turnover
6.21
6.23
3.72
Receivable days
164.30
113.22
129.01
Inventory Days
73.93
49.16
52.83
Payable days
52.71
29.10
5.40
Cash Conversion Cycle
185.52
133.28
176.44
Total Debt/Equity
1.36
1.04
4.63
Interest Cover
2.33
2.27
1.75

News Update:


  • Bandaram Pharma Packtech’s arm bags order worth Rs 3.86 crore
    29th May 2026, 16:45 PM

    The said order is expected to be completed between June- August 2026

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.